Trials / Recruiting
RecruitingNCT07462546
Transcranial Doppler for Internal Carotid Artery Stenting (TCD-ICAS)
Transcranial Doppler for Internal Carotid Artery Stenting (TCD-ICAS): A Prospective, Randomized Controlled, Blind Endpoint, Single-Center Study
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 232 (estimated)
- Sponsor
- General Hospital of Shenyang Military Region · Academic / Other
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
Carotid artery stenting (CAS) prevents stroke but carries risks of perioperative cerebral embolism. Transcranial Doppler (TCD) ultrasound can detect microemboli during CAS and may offer therapeutic benefits through ultrasound-enhanced thrombolysis. Trials like SONOBUSTER and SONOBIRDIE suggest TCD reduces new brain infarctions during carotid procedures. The TCD-ICAS trial will investigate whether TCD application during and after CAS reduces perioperative cerebral emboli and improves outcomes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Transcranial Doppler | TCD treatment (1.6 MHz, 0.274 MPa) from femoral artery puncture until 30-60 minutes after procedure completion |
Timeline
- Start date
- 2026-03-24
- Primary completion
- 2026-11-30
- Completion
- 2026-11-30
- First posted
- 2026-03-10
- Last updated
- 2026-03-25
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07462546. Inclusion in this directory is not an endorsement.